Boswellia Extract

Boswellia Extract

SuperiorLabs4.6 (36 ratings)
Format:Capsule Quantity: 240 Capsule(s) · 120 servings
Goals
$25.46 $0.21 per serving

Product analysis

52 out of 100

Boswellia Extract is aimed at joint comfort, but the preparation does not clearly match the specific extracts associated with symptom benefits. Black pepper is included without a demonstrated additional joint benefit.

AI assessment of the formula, label and price. How scoring works

Nutrient Quality36

Boswellic acids are named, but a specific quality advantage cannot be established for the extract. The leucine and black-pepper preparations remain unspecified.

Ingredient Transparency75

All ingredient amounts are listed, making the quantities easier to check. Only the boswellia preparation has form details, leaving leucine and black pepper less clear.

Value For Money38

Leucine is costly for the amount provided. Value for boswellia and black pepper cannot be established confidently.

Customer Satisfaction68

Customer feedback is very positive, but the number of reviews is small. The limited response makes satisfaction less certain than it would be with broader feedback.

Product Focus57

The blend is focused on joint comfort and related inflammatory processes. Benefits depend on the exact boswellia extract, and broader inflammation relief is uncertain.

Format
Capsule
Container
240 Capsule(s)
Per serving
$0.21
Customer rating
4.6 · 36 ratings
Report analysis

Goals

Impact
Moderate effect
C+ Ingredient FitF PathwaysF EvidenceA+ Formulation Logic
Boswellia · 500 mg
Study evidence
Boswellia Supportive 19 studies
Joint Health
Impact
Moderate effect
B+ Ingredient FitD- PathwaysF EvidenceA+ Formulation Logic
Boswellia · 500 mg
Study evidence
Boswellia Supportive 24 studies

Ingredients

IngredientAmount per servingScore
Indian Frankincense extract (Boswellic Acid)
500 mg 100
L-Leucine
100 mg 48
Black Pepper fruit extract
7.5 mg
Adults 18–50
Report overview
A+ Composition And Label DisclosureA+ Composition And Label Disclosure
A serving provides 500 mg of Boswellia serrata extract, with 65% boswellic acids. The amount and source are stated. No ingredient value conclusion is available.
How this ingredient is rated

Composition and Label Disclosure100

The available information lists 65% boswellic acids.
Marker and Preparation Disclosure
The available information lists 65% boswellic acids.

Composition and Label Disclosure100

The boswellia amount is stated.
Boswellia Amount and Marker Disclosure
The boswellia amount is stated.

Commercial Price and Usability

Ingredient value could not be determined.
Leucine · 100 mg OverallScore48
B- Active Ingredient Quality & BioavailabilityD- Dose, Safety & Label TransparencyF Value
100 mg of L-Leucine per serving comes at a high cost per gram, using the full serving price. The amount is too small to independently trigger muscle protein synthesis. Its source is not specified.
How this ingredient is rated

Active Ingredient Quality & Bioavailability70

L-Leucine is named, but its source is not specified.
Isomer Purity and Sourcing
L-Leucine is named, but its source is not specified.

Dose, Safety & Label Transparency40

The label states 100 mg per serving. That is too little to independently trigger muscle protein synthesis.
Muscle Protein Synthesis (MPS) Dosage
100 mg per serving is too little to independently trigger muscle protein synthesis.
Dosage Transparency
The label states the leucine amount per serving.

Value20

The cost per gram of leucine is high, based on the full serving price; this may overstate leucine's cost.
Price per Gram of Active Leucine
The cost per gram of leucine is high, based on the full serving price; this may overstate leucine's cost.
Report alternatives

Sources

Published studies used for the product analysis and the top-ranked studies for each ingredient and goal.

  1. Clinical Benefits of Boswellia Serrata (BOSMAX®) in Early Knee Osteoarthritis: A Randomized, Placebo-Controlled, Double-Blind Study.
    Jayaram M; Kim J; Baek KS; Jung H; Kim J; M K P; T S C; H B S; Ramaiah V; S P · Journal of medicinal food · 2025
    Randomized trial150 participantsInflammation forBoswellia
  2. A pilot, randomized, double-blind, placebo-controlled trial to assess the safety and efficacy of a novel Boswellia serrata extract in the management of osteoarthritis of the knee.
    Majeed M; Majeed S; Narayanan NK; Nagabhushanam K · Phytotherapy research : PTR · 2019
    Randomized trial48 participantsInflammation forBoswellia
  3. Boswellic Acids Improve Clinical Cognitive Scores and Reduce Systemic Inflammation in Patients with Mild to Moderate Alzheimer's Disease.
    Karima S; Aghamollaii V; Mahmoodi Baram S; Balenci L; Lanctôt KL; Kiss A; Tafakhori A; Mahdavi M; Rajaei S; Shateri S; Yarhoseini A; Mokhtari F; Fotouhi A; Riazi A · Journal of Alzheimer's disease : JAD · 2023
    Randomized trial85 participantsInflammation forBoswellia
  4. A Standardized Boswellia serrata Extract Improves Knee Joint Function and Cartilage Morphology in Human Volunteers with Mild to Moderate Osteoarthritis in a Randomized Placebo-Controlled Study.
    Kumar B; Ghaytidak AB; Pandey AK; Somepalli RR; Sarda P; Raychaudhuri SP; Rokkam MP · Journal of the American Nutrition Association · 2025
    Randomized trial80 participantsInflammation Joint Health forBoswellia
  5. A standardized Boswellia serrata extract shows improvements in knee osteoarthritis within five days-a double-blind, randomized, three-arm, parallel-group, multi-center, placebo-controlled trial.
    Majeed A; Majeed S; Satish G; Manjunatha R; Rabbani SN; Patil NVP; Mundkur L · Frontiers in pharmacology · 2024
    Randomized trial105 participantsInflammation Joint Health forBoswellia
  6. Oral herbal therapies for treating osteoarthritis.
    Cameron M; Chrubasik S · The Cochrane database of systematic reviews · 2015
    Meta-analysis5,980 participants49 studies pooledJoint Health forBoswellia
  7. Efficacy and safety of curcumin and its combination with boswellic acid in osteoarthritis: a comparative, randomized, double-blind, placebo-controlled study.
    Haroyan A; Mukuchyan V; Mkrtchyan N; Minasyan N; Gasparyan S; Sargsyan A; Narimanyan M; Hovhannisyan A · BMC complementary and alternative medicine · 2018
    Randomized trial201 participantsJoint Health forBoswellia
  8. A double blind, randomized, placebo controlled study of the efficacy and safety of 5-Loxin for treatment of osteoarthritis of the knee.
    Sengupta K; Alluri KV; Satish AR; Mishra S; Golakoti T; Sarma KV; Dey D; Raychaudhuri SP · Arthritis research & therapy · 2009
    Randomized trial75 participantsJoint Health forBoswellia